APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pruritus Therapeutics

Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.

In this report, we study the drugs for pruritus.

Selected research

Market Structure

Global Pruritus Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026198 pages

Choose your research edition.

Industry ResearchPruritus Therapeutics Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Pruritus Therapeutics Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Pruritus Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pruritus Therapeutics Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pruritus Therapeutics Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.

In this report, we study the drugs for pruritus.

Market competition is intense. J&J, Abbott, Amgen and LEO Pharma, etc. are the leaders of the industry, with about 60% market shares.

Read the full market overview

North America is the largest consumption place, with a revenue market share nearly 43%. Following North America, Europe is the second largest consumption place with the revenue market share of 27%.

Report Includes

This report provides an overview of the global Pruritus Therapeutics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pruritus Therapeutics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pruritus Therapeutics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pruritus Therapeutics market size, projected growth trends, production technologies, key applications, and end-use industries.

Pruritus Therapeutics Segment by Company

J&J

Abbott

Amgen

LEO Pharma

Novartis

Bayer

Pfizer

UCB Pharma

GlaxoSmithKline

Galderma

Huapont

Pruritus Therapeutics Segment by Type

Antihistamines

Corticosteroids

Calcineurin Inhibitors

Others

Pruritus Therapeutics Segment by Application

External Use

Oral

Injection

Pruritus Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pruritus Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pruritus Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pruritus Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pruritus Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pruritus Therapeutics industry.

Chapter 3: Detailed analysis of Pruritus Therapeutics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pruritus Therapeuticsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pruritus Therapeutics Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Antihistamines Table 3. Key Players of Corticosteroids Table 4. Key Players of Calcineurin Inhibitors Table 3. Key Players of Others Table 4. Global Pruritus Therapeutics Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of External Use Table 6. Key Players of Oral Table 7. Key Players of Injection Table 8. Global Pruritus Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Pruritus Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Pruritus Therapeutics Market Share by Region (2021-2026) Table 11. Global Pruritus Therapeutics Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Pruritus Therapeutics Market Share by Region (2027-2032) Table 13. Pruritus Therapeutics Industry Trends Table 14. Pruritus Therapeutics Industry Drivers Table 15. Pruritus Therapeutics Industry Opportunities and Challenges Table 16. Pruritus Therapeutics Industry Restraints Table 17. Global Pruritus Therapeutics Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Pruritus Therapeutics Revenue Market Share by Company (2021-2026) Table 19. Global Pruritus Therapeutics Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Pruritus Therapeutics Key Company Head Office and Area Served Table 21. Global Pruritus Therapeutics Company, Product Type & Application Table 22. Global Pruritus Therapeutics Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Pruritus Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Pruritus Therapeutics Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pruritus Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Pruritus Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Pruritus Therapeutics Revenue Market Share by Type (2021-2026) Table 29. Global Pruritus Therapeutics Revenue Market Share by Type (2027-2032) Table 30. Global Pruritus Therapeutics Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pruritus Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Pruritus Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Pruritus Therapeutics Revenue Market Share by Application (2021-2026) Table 34. Global Pruritus Therapeutics Revenue Market Share by Application (2027-2032) Table 35. J&J Company Information Table 36. J&J Business Overview Table 37. J&J Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. J&J Pruritus Therapeutics Product Portfolio Table 39. J&J Recent Development Table 40. Abbott Company Information Table 41. Abbott Business Overview Table 42. Abbott Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Abbott Pruritus Therapeutics Product Portfolio Table 44. Abbott Recent Development Table 45. Amgen Company Information Table 46. Amgen Business Overview Table 47. Amgen Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Amgen Pruritus Therapeutics Product Portfolio Table 49. Amgen Recent Development Table 50. LEO Pharma Company Information Table 51. LEO Pharma Business Overview Table 52. LEO Pharma Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. LEO Pharma Pruritus Therapeutics Product Portfolio Table 54. LEO Pharma Recent Development Table 55. Novartis Company Information Table 56. Novartis Business Overview Table 57. Novartis Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Novartis Pruritus Therapeutics Product Portfolio Table 59. Novartis Recent Development Table 60. Bayer Company Information Table 61. Bayer Business Overview Table 62. Bayer Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Bayer Pruritus Therapeutics Product Portfolio Table 64. Bayer Recent Development Table 65. Pfizer Company Information Table 66. Pfizer Business Overview Table 67. Pfizer Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Pfizer Pruritus Therapeutics Product Portfolio Table 69. Pfizer Recent Development Table 70. UCB Pharma Company Information Table 71. UCB Pharma Business Overview Table 72. UCB Pharma Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. UCB Pharma Pruritus Therapeutics Product Portfolio Table 74. UCB Pharma Recent Development Table 75. GlaxoSmithKline Company Information Table 76. GlaxoSmithKline Business Overview Table 77. GlaxoSmithKline Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. GlaxoSmithKline Pruritus Therapeutics Product Portfolio Table 79. GlaxoSmithKline Recent Development Table 80. Galderma Company Information Table 81. Galderma Business Overview Table 82. Galderma Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Galderma Pruritus Therapeutics Product Portfolio Table 84. Galderma Recent Development Table 85. Huapont Company Information Table 86. Huapont Business Overview Table 87. Huapont Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Huapont Pruritus Therapeutics Product Portfolio Table 89. Huapont Recent Development Table 90. North America Pruritus Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 91. North America Pruritus Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 92. North America Pruritus Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 93. North America Pruritus Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 94. North America Pruritus Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Pruritus Therapeutics Market Size by Country (2021-2026) Table 96. North America Pruritus Therapeutics Market Size by Country (2027-2032) Table 97. Europe Pruritus Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 98. Europe Pruritus Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 99. Europe Pruritus Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 100. Europe Pruritus Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 101. Europe Pruritus Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Pruritus Therapeutics Market Size by Country (2021-2026) Table 103. Europe Pruritus Therapeutics Market Size by Country (2027-2032) Table 104. China Pruritus Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 105. China Pruritus Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 106. China Pruritus Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 107. China Pruritus Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia Pruritus Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 109. Asia Pruritus Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 110. Asia Pruritus Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 111. Asia Pruritus Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 112. Asia Pruritus Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia Pruritus Therapeutics Market Size by Country (2021-2026) Table 114. Asia Pruritus Therapeutics Market Size by Country (2027-2032) Table 115. South America, Middle East & Africa Pruritus Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 116. South America, Middle East & Africa Pruritus Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 117. South America, Middle East & Africa Pruritus Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 118. South America, Middle East & Africa Pruritus Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 119. South America, Middle East & Africa Pruritus Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. South America, Middle East & Africa Pruritus Therapeutics Market Size by Country (2021-2026) Table 121. South America, Middle East & Africa Pruritus Therapeutics Market Size by Country (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Pruritus Therapeutics Product Image Figure 2. Global Pruritus Therapeutics Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pruritus Therapeutics Market Share by Type: 2025 VS 2032 Figure 4. Antihistamines Image Figure 5. Corticosteroids Image Figure 6. Calcineurin Inhibitors Image Figure 7. Others Image Figure 8. Global Pruritus Therapeutics Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Pruritus Therapeutics Market Share by Application: 2025 VS 2032 Figure 10. External Use Image Figure 11. Oral Image Figure 12. Injection Image Figure 13. Global Pruritus Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 15. Global Pruritus Therapeutics Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Pruritus Therapeutics Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Pruritus Therapeutics Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Pruritus Therapeutics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Pruritus Therapeutics Revenue Market Share by Type (2021-2032) Figure 22. Global Pruritus Therapeutics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Pruritus Therapeutics Revenue Market Share by Application (2021-2032) Figure 24. North America Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 25. North America Pruritus Therapeutics Market Share by Type (2021-2032) Figure 26. North America Pruritus Therapeutics Market Share by Application (2021-2032) Figure 27. North America Pruritus Therapeutics Market Share by Country (2021-2032) Figure 28. United States Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 29. Canada Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 31. Europe Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 32. Europe Pruritus Therapeutics Market Share by Type (2021-2032) Figure 33. Europe Pruritus Therapeutics Market Share by Application (2021-2032) Figure 34. Europe Pruritus Therapeutics Market Share by Country (2021-2032) Figure 35. Germany Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 36. France Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 38. Italy Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 39. Russia Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 41. China Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 42. China Pruritus Therapeutics Market Share by Type (2021-2032) Figure 43. China Pruritus Therapeutics Market Share by Application (2021-2032) Figure 44. Asia Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 45. Asia Pruritus Therapeutics Market Share by Type (2021-2032) Figure 46. Asia Pruritus Therapeutics Market Share by Application (2021-2032) Figure 47. Asia Pruritus Therapeutics Market Share by Country (2021-2032) Figure 48. Japan Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 52. India Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 53. Australia Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Pruritus Therapeutics Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Pruritus Therapeutics Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Pruritus Therapeutics Market Share by Country (2021-2032) Figure 58. Brazil Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 63. UAE Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 65. Chile Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Antihistamines
  • Corticosteroids
  • Calcineurin Inhibitors
  • Others
Applications
  • External Use
  • Oral
  • Injection
Companies covered
  • J&J
  • Abbott
  • Amgen
  • LEO Pharma
  • Novartis
  • Bayer
  • Pfizer
  • UCB Pharma
  • GlaxoSmithKline
  • Galderma
  • Huapont

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pruritus Therapeutics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Antihistamines
  5. 1.2.3 Corticosteroids
  6. 1.2.4 Calcineurin Inhibitors
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Pruritus Therapeutics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 External Use
  11. 1.3.3 Oral
  12. 1.3.4 Injection
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Pruritus Therapeutics Growth Trends by Region
  15. 1.5.1 Global Pruritus Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Pruritus Therapeutics Market Size by Region (2021-2026)
  17. 1.5.3 Pruritus Therapeutics Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Pruritus Therapeutics Market Dynamics
  1. 2.1 Pruritus Therapeutics Industry Trends
  2. 2.2 Pruritus Therapeutics Industry Drivers
  3. 2.3 Pruritus Therapeutics Industry Opportunities and Challenges
  4. 2.4 Pruritus Therapeutics Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pruritus Therapeutics Revenue by Company (2021-2026)
  2. 3.2 Global Pruritus Therapeutics Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pruritus Therapeutics Key Company Head office and Area Served
  4. 3.4 Global Pruritus Therapeutics Company, Product Type & Application
  5. 3.5 Global Pruritus Therapeutics Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pruritus Therapeutics Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pruritus Therapeutics Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pruritus Therapeutics Tier 1, Tier 2, and Tier 3
4 Pruritus Therapeutics Market by Type
  1. 4.1 Global Pruritus Therapeutics Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pruritus Therapeutics Market Size by Type (2021-2032)
  3. 4.3 Global Pruritus Therapeutics Market Size Share by Type (2021-2032)
5 Pruritus Therapeutics Market by Application
  1. 5.1 Global Pruritus Therapeutics Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pruritus Therapeutics Market Size by Application (2021-2032)
  3. 5.3 Global Pruritus Therapeutics Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 J&J
  2. 6.1.1 J&J Company Information
  3. 6.1.2 J&J Business Overview
  4. 6.1.3 J&J Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 J&J Pruritus Therapeutics Product Portfolio
  6. 6.1.5 J&J Recent Developments
  7. 6.2 Abbott
  8. 6.2.1 Abbott Company Information
  9. 6.2.2 Abbott Business Overview
  10. 6.2.3 Abbott Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Abbott Pruritus Therapeutics Product Portfolio
  12. 6.2.5 Abbott Recent Developments
  13. 6.3 Amgen
  14. 6.3.1 Amgen Company Information
  15. 6.3.2 Amgen Business Overview
  16. 6.3.3 Amgen Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Amgen Pruritus Therapeutics Product Portfolio
  18. 6.3.5 Amgen Recent Developments
  19. 6.4 LEO Pharma
  20. 6.4.1 LEO Pharma Company Information
  21. 6.4.2 LEO Pharma Business Overview
  22. 6.4.3 LEO Pharma Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 LEO Pharma Pruritus Therapeutics Product Portfolio
  24. 6.4.5 LEO Pharma Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Novartis Pruritus Therapeutics Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Bayer
  32. 6.6.1 Bayer Company Information
  33. 6.6.2 Bayer Business Overview
  34. 6.6.3 Bayer Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Bayer Pruritus Therapeutics Product Portfolio
  36. 6.6.5 Bayer Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Pfizer Pruritus Therapeutics Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 UCB Pharma
  44. 6.8.1 UCB Pharma Company Information
  45. 6.8.2 UCB Pharma Business Overview
  46. 6.8.3 UCB Pharma Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 UCB Pharma Pruritus Therapeutics Product Portfolio
  48. 6.8.5 UCB Pharma Recent Developments
  49. 6.9 GlaxoSmithKline
  50. 6.9.1 GlaxoSmithKline Company Information
  51. 6.9.2 GlaxoSmithKline Business Overview
  52. 6.9.3 GlaxoSmithKline Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 GlaxoSmithKline Pruritus Therapeutics Product Portfolio
  54. 6.9.5 GlaxoSmithKline Recent Developments
  55. 6.10 Galderma
  56. 6.10.1 Galderma Company Information
  57. 6.10.2 Galderma Business Overview
  58. 6.10.3 Galderma Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Galderma Pruritus Therapeutics Product Portfolio
  60. 6.10.5 Galderma Recent Developments
  61. 6.11 Huapont
  62. 6.11.1 Huapont Company Information
  63. 6.11.2 Huapont Business Overview
  64. 6.11.3 Huapont Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Huapont Pruritus Therapeutics Product Portfolio
  66. 6.11.5 Huapont Recent Developments
7 North America
  1. 7.1 North America Pruritus Therapeutics Market Size (2021-2032)
  2. 7.2 North America Pruritus Therapeutics Market Size by Type
  3. 7.2.1 North America Pruritus Therapeutics Market Size by Type (2021-2026)
  4. 7.2.2 North America Pruritus Therapeutics Market Size by Type (2027-2032)
  5. 7.2.3 North America Pruritus Therapeutics Market Share by Type (2021-2032)
  6. 7.3 North America Pruritus Therapeutics Market Size by Application
  7. 7.3.1 North America Pruritus Therapeutics Market Size by Application (2021-2026)
  8. 7.3.2 North America Pruritus Therapeutics Market Size by Application (2027-2032)
  9. 7.3.3 North America Pruritus Therapeutics Market Share by Application (2021-2032)
  10. 7.4 North America Pruritus Therapeutics Market Size by Country
  11. 7.4.1 North America Pruritus Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pruritus Therapeutics Market Size by Country (2021-2026)
  13. 7.4.3 North America Pruritus Therapeutics Market Size by Country (2027-2032)
  14. 7.4.4 North America Pruritus Therapeutics Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pruritus Therapeutics Market Size (2021-2032)
  2. 8.2 Europe Pruritus Therapeutics Market Size by Type
  3. 8.2.1 Europe Pruritus Therapeutics Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pruritus Therapeutics Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pruritus Therapeutics Market Share by Type (2021-2032)
  6. 8.3 Europe Pruritus Therapeutics Market Size by Application
  7. 8.3.1 Europe Pruritus Therapeutics Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pruritus Therapeutics Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pruritus Therapeutics Market Share by Application (2021-2032)
  10. 8.4 Europe Pruritus Therapeutics Market Size by Country
  11. 8.4.1 Europe Pruritus Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pruritus Therapeutics Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pruritus Therapeutics Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pruritus Therapeutics Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pruritus Therapeutics Market Size (2021-2032)
  2. 9.2 China Pruritus Therapeutics Market Size by Type
  3. 9.2.1 China Pruritus Therapeutics Market Size by Type (2021-2026)
  4. 9.2.2 China Pruritus Therapeutics Market Size by Type (2027-2032)
  5. 9.2.3 China Pruritus Therapeutics Market Share by Type (2021-2032)
  6. 9.3 China Pruritus Therapeutics Market Size by Application
  7. 9.3.1 China Pruritus Therapeutics Market Size by Application (2021-2026)
  8. 9.3.2 China Pruritus Therapeutics Market Size by Application (2027-2032)
  9. 9.3.3 China Pruritus Therapeutics Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pruritus Therapeutics Market Size (2021-2032)
  2. 10.2 Asia Pruritus Therapeutics Market Size by Type
  3. 10.2.1 Asia Pruritus Therapeutics Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pruritus Therapeutics Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pruritus Therapeutics Market Share by Type (2021-2032)
  6. 10.3 Asia Pruritus Therapeutics Market Size by Application
  7. 10.3.1 Asia Pruritus Therapeutics Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pruritus Therapeutics Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pruritus Therapeutics Market Share by Application (2021-2032)
  10. 10.4 Asia Pruritus Therapeutics Market Size by Country
  11. 10.4.1 Asia Pruritus Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pruritus Therapeutics Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pruritus Therapeutics Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pruritus Therapeutics Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pruritus Therapeutics Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pruritus Therapeutics Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pruritus Therapeutics Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pruritus Therapeutics Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pruritus Therapeutics Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pruritus Therapeutics Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pruritus Therapeutics Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pruritus Therapeutics Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pruritus Therapeutics Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pruritus Therapeutics Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pruritus Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pruritus Therapeutics Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pruritus Therapeutics Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pruritus Therapeutics Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst